184 related articles for article (PubMed ID: 29707232)
1. Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Karki C; Liu M; Kavanaugh A; Ritchlin CT; Huynh DH; Palmer JB; Greenberg JD
RMD Open; 2018; 4(1):e000638. PubMed ID: 29707232
[TBL] [Abstract][Full Text] [Related]
2. Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Palmer JB; Liu M; Kavanaugh A; Pandurengan R; Ritchlin CT; Karki C; Greenberg JD
J Rheumatol; 2018 Oct; 45(10):1389-1396. PubMed ID: 29961691
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Liu M; Rebello S; Hua W; McLean RR; Yi E; Park Y; Ogdie A
ACR Open Rheumatol; 2020 Jul; 2(7):449-456. PubMed ID: 32627974
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry.
Mease PJ; van der Heijde D; Karki C; Liu M; Park Y; Greenberg JD
Rheumatol Ther; 2018 Dec; 5(2):537-550. PubMed ID: 30353387
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Men and Women With Axial Spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; McLean RR; Dube B; Liu M; Rebello S; Glynn M; Yi E; Park Y; Ogdie A
J Rheumatol; 2021 Oct; 48(10):1528-1536. PubMed ID: 33858974
[TBL] [Abstract][Full Text] [Related]
7. Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry.
Rahman P; Zummer M; Bessette L; Baer P; Haraoui B; Chow A; Kelsall J; Kapur S; Rampakakis E; Psaradellis E; Lehman AJ; Nantel F; Osborne B; Tkaczyk C
BMJ Open; 2017 Aug; 7(8):e016619. PubMed ID: 28855200
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Young P; Fallon L; Mundayat R; Dina O; Blachley T; Middaugh N; Ogdie A
Rheumatol Ther; 2024 Apr; 11(2):313-329. PubMed ID: 38252211
[TBL] [Abstract][Full Text] [Related]
9. Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
Sunar I; Ataman S; Nas K; Kilic E; Sargin B; Kasman SA; Alkan H; Sahin N; Cengiz G; Cuzdan N; Gezer IA; Keskin D; Mülkoğlu C; Resorlu H; Bal A; Duruöz MT; Küçükakkaş O; Yurdakul OV; Melikoglu MA; Aydın Y; Ayhan FF; Bodur H; Calis M; Capkın E; Devrimsel G; Gok K; Hizmetli S; Kamanlı A; Keskin Y; Kocabas H; Kutluk O; Şen N; Şendur OF; Tekeoğlu I; Tolu S; Toprak M; Tuncer T
Rheumatol Int; 2020 Feb; 40(2):283-294. PubMed ID: 31773391
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease-modifying antirheumatic drug prescribing.
Pontifex EK; Dissanayake K; Bursill D; Gill T
Int J Rheum Dis; 2019 Feb; 22(2):262-268. PubMed ID: 30450819
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
J Rheumatol; 2017 Aug; 44(8):1151-1158. PubMed ID: 28620063
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Blachley T; Dube B; McLean RR; Kim N; Hur P; Ogdie A
J Rheumatol; 2022 Jul; 49(7):700-706. PubMed ID: 35428716
[TBL] [Abstract][Full Text] [Related]
13. Residual Disease Burden in Patients With Axial Spondyloarthritis and Psoriatic Arthritis Despite Low Disease Activity States in a Multiethnic Asian Population.
Liu V; Fong W; Kwan YH; Leung YY
J Rheumatol; 2021 May; 48(5):677-684. PubMed ID: 33132217
[TBL] [Abstract][Full Text] [Related]
14. Effect of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Ogdie A; Hur P; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Mease PJ
J Rheumatol; 2021 May; 48(5):698-706. PubMed ID: 33004532
[TBL] [Abstract][Full Text] [Related]
15. Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Hur P; Ogdie A
J Rheumatol; 2021 Apr; 48(4):520-526. PubMed ID: 33060307
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry.
Mease PJ; Karki C; Liu M; Li Y; Gershenson B; Feng H; Hur P; Greenberg JD
RMD Open; 2019; 5(1):e000880. PubMed ID: 31168408
[TBL] [Abstract][Full Text] [Related]
17. Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study.
Coates LC; Rahman P; Mease PJ; Shawi M; Rampakakis E; Kollmeier AP; Xu XL; Chakravarty SD; McInnes IB; Tam LS
BMC Rheumatol; 2024 Feb; 8(1):6. PubMed ID: 38310261
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
Lubrano E; Parsons WJ; Perrotta FM
J Rheumatol; 2016 May; 43(5):918-23. PubMed ID: 26980581
[TBL] [Abstract][Full Text] [Related]
19. Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen-B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Chakravarty SD; McLean RR; Blachley T; Kawashima T; Lin I; Kavanaugh A; Ogdie A
ACR Open Rheumatol; 2022 May; 4(5):447-456. PubMed ID: 35218320
[TBL] [Abstract][Full Text] [Related]
20. Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: A multi-center study.
Duruöz MT; Gezer HH; Nas K; Kılıç E; Sargın B; Kasman SA; Alkan H; Şahin N; Cengiz G; Cüzdan N; Gezer İA; Keskin D; Mülkoğlu C; Reşorlu H; Ataman Ş; Bal A; Küçükakkaş O; Yurdakul OV; Melikoğlu MA; Baykul M; Ayhan FF; Bodur H; Çalış M; Çapkın E; Devrimsel G; Gök K; Hizmetli S; Kamanlı A; Keskin Y; Ecesoy H; Kutluk Ö; Şen N; Şendur ÖF; Tekeoğlu İ; Tolu S; Toprak M; Tuncer T
Joint Bone Spine; 2021 Jul; 88(4):105177. PubMed ID: 33771757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
